[go: up one dir, main page]

AU1117999A - Amelioration of ischemic damage using synthetic oxygen carriers - Google Patents

Amelioration of ischemic damage using synthetic oxygen carriers

Info

Publication number
AU1117999A
AU1117999A AU11179/99A AU1117999A AU1117999A AU 1117999 A AU1117999 A AU 1117999A AU 11179/99 A AU11179/99 A AU 11179/99A AU 1117999 A AU1117999 A AU 1117999A AU 1117999 A AU1117999 A AU 1117999A
Authority
AU
Australia
Prior art keywords
amelioration
ischemic damage
oxygen carriers
synthetic oxygen
synthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11179/99A
Other languages
English (en)
Inventor
N. Simon Faithfull
Stephen F Flaim
Peter E. Keipert
Gwen H Rosenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alliance Pharmaceutical Corp
Original Assignee
Alliance Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alliance Pharmaceutical Corp filed Critical Alliance Pharmaceutical Corp
Publication of AU1117999A publication Critical patent/AU1117999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU11179/99A 1997-10-24 1998-10-23 Amelioration of ischemic damage using synthetic oxygen carriers Abandoned AU1117999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6350297P 1997-10-24 1997-10-24
US60063502 1997-10-24
PCT/US1998/022491 WO1999021541A2 (fr) 1997-10-24 1998-10-23 Traitement des lesions ischemiques par des transporteurs d'oxygene synthetiques

Publications (1)

Publication Number Publication Date
AU1117999A true AU1117999A (en) 1999-05-17

Family

ID=22049637

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11179/99A Abandoned AU1117999A (en) 1997-10-24 1998-10-23 Amelioration of ischemic damage using synthetic oxygen carriers

Country Status (3)

Country Link
EP (1) EP1023058A2 (fr)
AU (1) AU1117999A (fr)
WO (1) WO1999021541A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE296814T1 (de) * 1999-05-12 2005-06-15 Neurosearch As Ionenkanal modulierende mittel
GB9919131D0 (en) * 1999-08-14 1999-10-13 Depuy Int Ltd Joint lubrication
GB0408164D0 (en) 2004-04-13 2004-05-19 Immune Targeting Systems Ltd Antigen delivery vectors and constructs
GB0716992D0 (en) 2007-08-31 2007-10-10 Immune Targeting Systems Its L Influenza antigen delivery vectors and constructs
US7794699B2 (en) 2005-01-05 2010-09-14 Michigan Molecular Institute Nano-structured blood substitutes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4445886A (en) * 1980-04-14 1984-05-01 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US5085630A (en) * 1980-04-14 1992-02-04 Thomas Jefferson University Oxygenated fluorocarbon nutrient solution
US4378797A (en) * 1980-04-14 1983-04-05 Thomas Jefferson University Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US5137510A (en) * 1990-12-14 1992-08-11 Mallinckrodt Medical, Inc. System and method for oxygenation of the heart using subpericardial fluids
HUP9900879A2 (hu) * 1995-06-07 1999-08-30 Alliance Pharmaceutical Corp. Fordított fluor-szénhidrogén emulziós készítmények gyógyszeradagoláshoz

Also Published As

Publication number Publication date
EP1023058A2 (fr) 2000-08-02
WO1999021541A2 (fr) 1999-05-06
WO1999021541A3 (fr) 1999-08-05

Similar Documents

Publication Publication Date Title
AU1407699A (en) Distributed architecture utility
AU5686398A (en) Asymmetric multiple electrode support structures
AUPN827696A0 (en) Dynamic special symbols
AU7872898A (en) Percarboxylic acid solutions
AU3658995A (en) Cable carriers
AU1785497A (en) Brick support
AU2124697A (en) Synthetic hiv genes
AU2909597A (en) Use of hollow microcapsules
AU738809C (en) Novel liposomal active-principle vectors
AU1124099A (en) Double ended carrier
AU1600597A (en) Stabilisation of polyolefin-recyclates
AU4632297A (en) Microcapsules
AU1117999A (en) Amelioration of ischemic damage using synthetic oxygen carriers
AU3025797A (en) Supporting article
AU7067598A (en) Support structure
AU9655698A (en) Synthetic genes with immunomodulatory effects
AU5589698A (en) Improved substrates and colorant stabilizers
AU4422897A (en) Cross-dimerization of olefins
AU4921597A (en) Retractable anti-rebound support
AU3363997A (en) Means of transport with increased range
AU1363997A (en) Hair support structure
AU4205497A (en) Bioreactor
AU3323197A (en) Improved support
AU3438297A (en) Defined enzyme mixtures for cosmetic purposes
AU4850597A (en) Fabricated structural members

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase